Revoras is a comprehensive advanced imaging platform that is the newest generation Ziosoft technology
CHICAGO (PRWEB) November 28, 2022
Ziosoft, a pioneer in 3D/4D AI medical visualization, is introducing its newest software for its flagship Ziostation system at the annual Radiologicaly Society of North America (RSNA) being held November 27-30, 2022 in Chicago. The Revoras platform (work in progress) offers numerous productivity enhancements and new visualization technology including the unique Ziosoft Rembrandt image rendering capability.
“Rembrandt, the artist, was a master in creating realistic 3D figures and was the gold standard in the golden age of art,” said Shusuke Chino, co-founder and president, Ziosoft. “Like this revolutionary artist, our unique, vendor- neutral Rembrandt image rendering capability is designed to transform or reimagine 3D medical image viewing. It is enabled, along with other enhancements, through our new, advanced Revoras platform, which is being introduced at RSNA this year.”
Chino also emphasized that diagnostic imaging is at the forefront of healthcare digital progression, paving the way for advanced visualization solutions to be a definitive gold standard. Advanced imaging technology immerses users in simulated environments for exploration, analysis, synthesis and presentation, all of which are enabled by the Revoras platform.
In addition to the Rembrandt viewing capability, the Revoras platform provides complex protocol workflows, which are made simpler using accelerated automation for faster processing and reduced training burdens. Revoras harnesses the power of AI within the platform to optimize the reproducible results, helping to enable life-changing therapies faster. For example, the clinician is able to fast- track calcium scoring reading using AI-powered automation. Revoras also scales and simplifies workflow across the enterprise using its rich and comprehensive image-processing package available on any independent hardware - a true vendor-neutral platform.
“Revoras is a comprehensive advanced imaging platform that is the newest generation Ziosoft technology,” said Rajeev Taitriya, vice president of marketing and business development for Ziosoft. “It's Ziostation2 with a new look, which is easier, faster and has more reproducible workflows. It is available to current Ziostation2 customers as an option, as well as to our Zioflex monthly subscription holders.”
The Ziosoft platform offers Zioflex, a monthly subscription program designed to provide a risk- free introduction of to Ziosoft’s many advanced visualization clinical applications. The software is vendor- neutral and can be compatible with the clinician’s existing hardware, hence mitigating the need for expensive capital outlays.
Ziosoft provides a comprehensive multi-modality, 3D/4D advanced processing and viewing solution for a wide variety of specialties. Its customizable platform provides automated workflow to maximize efficiency. It is also a scalable, enterprise platform for "anywhere" accessibility and, as a software-only solution, it is simplified to minimize cost of ownership. Ziosoft is part of the Los Angeles-based Nantworks a consortium of companies led by Patrick Soon-Shiong, MD, the past founder of Abraxis BioScience, current CEO of Nantworks, founder, executive chairman and chief science officer for ImmunityBio. He is also the owner of the Los Angeles Times and San Diego Tribune. For further information on Ziosoft, visit http://www.ziosoftinc.com.
# # #